Tranxene T-Tab® Tablets (clorazepate dipotassium tablets, USP) 7.5mg Trade Notification Product Availability 09/23/2020 Recordati Rare Diseases Announces Availability of CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37% in the U.S. 09/15/2020 U.S. FDA Approves CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37%, A New Practical Treatment Option for the Ocular Manifestations of Cystinosis 08/25/2020 Pagination First page « First Previous page ‹ Previous … Page 7 Current page 8 Page 9 Page 10 … Next page Next › Last page Last »
Tranxene T-Tab® Tablets (clorazepate dipotassium tablets, USP) 7.5mg Trade Notification Product Availability 09/23/2020
Recordati Rare Diseases Announces Availability of CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37% in the U.S. 09/15/2020
U.S. FDA Approves CYSTADROPS® (Cysteamine Ophthalmic Solution) 0.37%, A New Practical Treatment Option for the Ocular Manifestations of Cystinosis 08/25/2020
